---
title: "Bosutinib - Blastic phase of chronic myeloid leukemia"
sidebar: mydoc_sidebar
permalink: db06616-mesh-d001752-1.html
toc: false 
---


Path ID: `DB06616_MESH_D001752_1`
{% include image.html url="images/db06616-mesh-d001752-1.png" file="db06616-mesh-d001752-1.png" alt="db06616-mesh-d001752-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C471992 | Bosutinib | Drug |
| UniProt:A9UF02 | BCR/ABL protein-tyrosine kinase | Protein |
| MESH:D001752 | Blastic phase of chronic myeloid leukemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Bosutinib | DECREASES ACTIVITY OF | Bcr/Abl Protein-Tyrosine Kinase |
| Bcr/Abl Protein-Tyrosine Kinase | CAUSES | Blastic Phase Of Chronic Myeloid Leukemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06616](https://go.drugbank.com/drugs/DB06616)
